These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5032310)

  • 1. Drug information to contain NAC study results.
    Pa Med; 1972 Jul; 75(7):20. PubMed ID: 5032310
    [No Abstract]   [Full Text] [Related]  

  • 2. A survey of developments in food and drug law from July 1998 to November 1999.
    Littlefield N; Hada NR
    Food Drug Law J; 2000; 55(1):35-56. PubMed ID: 12296348
    [No Abstract]   [Full Text] [Related]  

  • 3. Black box warnings in prescription drug labeling: results of a survey of 206 drugs.
    Beach JE; Faich GA; Bormel FG; Sasinowski FJ
    Food Drug Law J; 1998; 53(3):403-11. PubMed ID: 10346718
    [No Abstract]   [Full Text] [Related]  

  • 4. The regulatory role of the United States Food and Drug Administration.
    Ortiz EM
    J Reprod Med; 1972 Apr; 8(4):205-6. PubMed ID: 5029971
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug labeling for teratogenicity: requirements of the U.S. Food and Drug Administration.
    Kelsey FO
    Prog Clin Biol Res; 1985; 163C():155-9. PubMed ID: 3991617
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA in hot water again over cost of proposed drug labeling rule.
    Demkovich LE
    Natl J (Wash); 1979 Sep; 11(38):1568-70. PubMed ID: 10243426
    [No Abstract]   [Full Text] [Related]  

  • 7. The history of patient package inserts in the United States.
    Moore SR; Morris LA; Groft SC
    Can Pharm J; 1981 May; 114(5):173-5. PubMed ID: 10251273
    [No Abstract]   [Full Text] [Related]  

  • 8. Professional drug labeling.
    Terry M
    J Am Vet Med Assoc; 1993 May; 202(10):1711-2;discussion 1713-7. PubMed ID: 8514591
    [No Abstract]   [Full Text] [Related]  

  • 9. Is it worth the trouble? The new policy on dissemination of information on off-label drug use under the Food and Drug Administration Modernization Act of 1997.
    Weeks EA
    Food Drug Law J; 1999; 54(4):645-65. PubMed ID: 11824459
    [No Abstract]   [Full Text] [Related]  

  • 10. AVMA legislation: partial solution to drug availability problem.
    Gloyd JS
    J Am Vet Med Assoc; 1993 Apr; 202(7):1055-6. PubMed ID: 8473213
    [No Abstract]   [Full Text] [Related]  

  • 11. Doctors are focus of some sweeping changes being dusted off in Drug Reform Act.
    Hornett P
    Leg Aspects Med Pract; 1978 Aug; 6(8):54-7. PubMed ID: 703483
    [No Abstract]   [Full Text] [Related]  

  • 12. Prescription drug products; patient labeling requirements: proposed rule.
    Fed Regist; 1979 Jul; 44(131 Pt 2):40015-41. PubMed ID: 10242793
    [No Abstract]   [Full Text] [Related]  

  • 13. Content and format for labeling for human prescription drugs; amendment of effective date for certain biological products--Food and Drug Administration. Final rule.
    Fed Regist; 1981 Jan; 46(15 pt 1):7271-3. PubMed ID: 10249526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Over-the-counter human drugs; labeling requirements; final rule; technical amendment. Food and Drug Administration, HHS. Final rule; technical amendment.
    Fed Regist; 2000 Jan; 65(1):7-9. PubMed ID: 11010625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The medicolegal significance of the package insert.
    Hirsh HL
    Med Trial Tech Q; 1976; 23(2):143-50. PubMed ID: 1004155
    [No Abstract]   [Full Text] [Related]  

  • 16. Wyeth preemption case ruling sparks labeling confusion.
    Allison M
    Nat Biotechnol; 2009 May; 27(5):399-400. PubMed ID: 19430423
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of drugs for unapproved indications: your legal responsibility.
    Eye Ear Nose Throat Mon; 1972 Dec; 51(12):493-5. PubMed ID: 4637969
    [No Abstract]   [Full Text] [Related]  

  • 18. Mandatory PPIs to begin in 1981; APhA issues strong objections.
    Small WE
    Am Pharm; 1980 Nov; NS20(11):10-1. PubMed ID: 7457342
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA acts on estrogen, progestin labeling.
    FDA Consum; 1977 Nov; 11(9):3. PubMed ID: 10305006
    [No Abstract]   [Full Text] [Related]  

  • 20. Weiss wants extra-label use policy eliminated.
    Gloyd JS
    J Am Vet Med Assoc; 1990 Mar; 196(6):838-9. PubMed ID: 2312378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.